{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T21:25:57Z","timestamp":1793049957373,"version":"4.5.0"},"reference-count":185,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T00:00:00Z","timestamp":1744156800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Disease (NIAID)","doi-asserted-by":"publisher","award":["R01AI119380-06"],"award-info":[{"award-number":["R01AI119380-06"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Disease (NIAID)","doi-asserted-by":"publisher","award":["P30-GM145393"],"award-info":[{"award-number":["P30-GM145393"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences (NIGMS)","doi-asserted-by":"publisher","award":["R01AI119380-06"],"award-info":[{"award-number":["R01AI119380-06"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences (NIGMS)","doi-asserted-by":"publisher","award":["P30-GM145393"],"award-info":[{"award-number":["P30-GM145393"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Texas Hip and Knee Center","award":["R01AI119380-06"],"award-info":[{"award-number":["R01AI119380-06"]}]},{"name":"Texas Hip and Knee Center","award":["P30-GM145393"],"award-info":[{"award-number":["P30-GM145393"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Microorganisms"],"abstract":"<jats:p>Staphylococcus aureus is one of the most diverse bacterial pathogens. This is reflected in its ability to cause a wide array of infections and in genotypic and phenotypic differences between clinical isolates that extend beyond their antibiotic resistance status. Many S. aureus infections, including those involving indwelling medical devices, are therapeutically defined by the formation of a biofilm. This is reflected in the number of reports focusing on S. aureus biofilm formation and biofilm-associated infections. These infections are characterized by a level of intrinsic resistance that compromises conventional antibiotic therapy irrespective of acquired resistance, suggesting that an inhibitor of biofilm formation would have tremendous clinical value. Many reports have described large-scale screens aimed at identifying compounds that limit S. aureus biofilm formation, but relatively few examined whether the limitation was sufficient to overcome this intrinsic resistance. Similarly, while many of these reports examined the impact of putative inhibitors on S. aureus phenotypes, very few took a focused approach to identify and optimize an effective inhibitor of specific biofilm-associated targets. Such approaches are dependent on validating a target, hopefully one that is not restricted by the diversity of S. aureus as a bacterial pathogen. Rigorous biological validation of such a target would allow investigators to virtually screen vast chemical libraries to identify potential inhibitors that warrant further investigation based on their predicted function. Here, we summarize reports describing S. aureus regulatory loci implicated in biofilm formation to assess whether they are viable targets for the development of an anti-biofilm therapeutic strategy with an emphasis on whether sarA has been sufficiently validated to warrant consideration in this important clinical context.<\/jats:p>","DOI":"10.3390\/microorganisms13040852","type":"journal-article","created":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T11:26:41Z","timestamp":1744284401000},"page":"852","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Staphylococcus aureus Biofilm-Associated Infections: Have We Found a Clinically Relevant Target?"],"prefix":"10.3390","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9152-8198","authenticated-orcid":false,"given":"Karen E.","family":"Beenken","sequence":"first","affiliation":[{"name":"Department of Microbiology and Immunology, University of Arkansas for Medical Sciences, Little Rock, AR 72205, USA"},{"name":"Department of Biochemistry and Molecular Biology, University of Arkansas for Medical Sciences, Little Rock, AR 72205, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0878-0692","authenticated-orcid":false,"given":"Mark S.","family":"Smeltzer","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Immunology, University of Arkansas for Medical Sciences, Little Rock, AR 72205, USA"},{"name":"Department of Orthopaedic Surgery, University of Arkansas for Medical Sciences, Little Rock,  AR 72205, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,4,9]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Abdelhamid, A.B., and Yousef, A.E. (2022). Combating bacterial biofilms: Current and emerging antibiofilm strategies for treating persistent infections. Antibiotics, 12.","DOI":"10.3390\/antibiotics12061005"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1038\/s41579-022-00682-4","article-title":"Tolerance and resistance of microbial biofilms","volume":"20","author":"Coifu","year":"2022","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Gimza, B.D., and Cassat, J.E. (2021). Mechanisms of antibiotic failure during Staphylococcus Aureus Osteomyelitis. Front. Immunol., 12.","DOI":"10.3389\/fimmu.2021.638085"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/13543784.2024.2305136","article-title":"Approaches to combating methicillin-resistant Staphylococcus aureus (MRSA) biofilm infections","volume":"33","author":"Le","year":"2024","journal-title":"Expert. Opin. Investig. Drugs"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s12178-018-9501-4","article-title":"Staphylococcus aureus evasion of host immunity in the setting of prosthetic joint infection: Biofilm and beyond","volume":"11","author":"Ricciardi","year":"2018","journal-title":"Curr. Rev. Musculoskelet. Med."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1002\/phar.2806","article-title":"Current therapies and challenges for the treatment of Staphylococcus aureus biofilm-related infections","volume":"43","author":"Tran","year":"2023","journal-title":"Pharmacotherapy"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1146\/annurev.mi.41.100187.002251","article-title":"Bacterial biofilms in nature and disease","volume":"41","author":"Costerton","year":"1987","journal-title":"Annu. Rev. Microbiol."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Kragh, K.N., Tolker-Nielsen, T., and Lichtenberg, M. (2023). The non-attached biofilm aggregate. Commun. Biol., 6.","DOI":"10.1038\/s42003-023-05281-4"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"e00293-20","DOI":"10.1128\/IAI.00293-20","article-title":"Three-dimensional in vitro Staphylococcus aureus abscess communities display antibiotic tolerance and protection from neutrophil clearance","volume":"88","author":"Hofstee","year":"2020","journal-title":"Infect. Immun."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1128\/AAC.02750-15","article-title":"Regulatory mutations impacting antibiotic susceptibility in an established Staphylococcus aureus biofilm","volume":"60","author":"Atwood","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Johansen, M.I., Petersen, M.E., Faddy, E., Seefeldt, A.M., Mitkin, A.A., \u00d8stergaard, L., Meyer, R.L., and J\u00f8rgensen, N.P. (2024). Efficacy of rifampicin combination therapy against MRSA prosthetic vascular graft infections in a rat model. Biofilm, 7.","DOI":"10.1016\/j.bioflm.2024.100189"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"5688","DOI":"10.1128\/AAC.01251-16","article-title":"Evaluation of antibiotics active against methicillin-resistant Staphylococcus aureus based on activity in an established biofilm","volume":"60","author":"Meeker","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.avsg.2024.05.038","article-title":"Antibiotic efficacy against methicillin-susceptible Staphylococcus aureus biofilms on synthetic and biological vascular grafts","volume":"108","author":"Palau","year":"2024","journal-title":"Ann. Vasc. Surg."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.mib.2011.09.002","article-title":"Heterogeneous bacterial persisters and engineering approaches to eliminate them","volume":"14","author":"Allison","year":"2011","journal-title":"Curr. Opin. Microbiol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1038\/nrmicro3076","article-title":"A problem of persistence: Still more questions than answers","volume":"11","author":"Balaban","year":"2013","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/ja.2014.115","article-title":"Small colony variants have a major role in stability and persistence of Staphylococcus aureus biofilms","volume":"68","author":"Mirani","year":"2015","journal-title":"J. Antibiot."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1080\/1040841X.2022.2159319","article-title":"Emergence of persister cells in Staphylococcus aureus: Calculated or fortuitous move?","volume":"50","author":"Vasudevan","year":"2024","journal-title":"Crit. Rev. Microbiol."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Waters, E.M., Rowe, S.E., O\u2019Gara, J.P., and Conlon, B.P. (2016). 2016. Convergence of Staphylococcus aureus persister and biofilm research: Can biofilms be defined as communities of adherent persister cells?. PLoS Pathog., 12.","DOI":"10.1371\/journal.ppat.1006012"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1002\/mbo3.250","article-title":"Comparative impact of diverse regulatory loci on Staphylococcus aureus biofilm formation","volume":"4","author":"Atwood","year":"2015","journal-title":"Microbiologyopen"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"2175496","DOI":"10.1080\/21505594.2023.2175496","article-title":"The major role of sarA in limiting Staphylococcus aureus extracellular protease production in vitro is correlated with decreased virulence in diverse clinical isolates in osteomyelitis","volume":"14","author":"Campbell","year":"2023","journal-title":"Virulence"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"e00530-19","DOI":"10.1128\/IAI.00530-19","article-title":"The impact of msaABCR on sarA-associated phenotypes are different in divergent clinical isolates of Staphylococcus aureus","volume":"88","author":"Rom","year":"2020","journal-title":"Infect. Immun."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1128\/microbiolspec.GPP3-0031-2018","article-title":"Regulation of Staphylococcus aureus virulence","volume":"7","author":"Jenul","year":"2019","journal-title":"Microbiol. Spectr."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"e00932-19","DOI":"10.1128\/IAI.00932-19","article-title":"Staphylococcus aureus osteomyelitis: Bone, bugs, and surgery","volume":"88","author":"Urish","year":"2020","journal-title":"Infect. Immun."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1080\/14787210.2017.1372192","article-title":"Advances in the local and targeted delivery of anti-infective agents for management of osteomyelitis. Expert Rev","volume":"15","author":"Ford","year":"2017","journal-title":"Anti Infect. Ther."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"22","DOI":"10.2174\/1871526516666160407113646","article-title":"Prosthetic joint and orthopedic device related infections. The role of biofilm in the pathogenesis and treatment","volume":"16","author":"Antony","year":"2016","journal-title":"Infect. Disord. Drug Targets."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"190S","DOI":"10.1097\/PRS.0b013e3182025070","article-title":"Surgical treatment of osteomyelitis","volume":"127","author":"Cierny","year":"2011","journal-title":"Plast. Reconstr. Surg."},{"key":"ref_27","first-page":"CD004439","article-title":"Antibiotics for treating chronic osteomyelitis in adults","volume":"6","author":"Conterno","year":"2013","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.5435\/JAAOS-D-14-00394","article-title":"The economic significance of orthopaedic infections","volume":"23","author":"Hackett","year":"2015","journal-title":"J. Am. Acad. Orthop. Surg."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1016\/j.arth.2020.12.005","article-title":"Projected economic burden of periprosthetic joint infection of the hip and knee in the United States","volume":"36","author":"Premkumar","year":"2021","journal-title":"J. Arthroplas."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"837","DOI":"10.2106\/JBJS.N.01350","article-title":"Trends in the epidemiology of osteomyelitis: A population-based study, 1969\u20132009","volume":"97","author":"Kremers","year":"2015","journal-title":"J. Bone Joint Surg. Am."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/s41579-022-00686-0","article-title":"Skeletal infections: Microbial pathogenesis, immunity and clinical management","volume":"20","author":"Masters","year":"2022","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/s11914-019-00548-4","article-title":"Mechanisms of immune evasion and bone tissue colonization that make Staphylococcus aureus the primary pathogen in osteomyelitis","volume":"17","author":"Muthukrishnan","year":"2019","journal-title":"Curr. Osteoporos. Rep."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1002\/jor.1100150314","article-title":"Characterization of a rabbit model of staphylococcal osteomyelitis","volume":"15","author":"Smeltzer","year":"1997","journal-title":"J. Orthop. Res."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Masters, E.A., Muthukrishnan, G., Ho, L., Gill, A.L., de Mesy Bentley, K.L., Galloway, C.A., McGrath, J.L., Awad, H.A., Gill, S.R., and Schwarz, E.M. (2021). Staphylococcus aureus cell wall biosynthesis modulates bone invasion and osteomyelitis pathogenesis. Front. Microbiol., 12.","DOI":"10.3389\/fmicb.2021.723498"},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Josse, J., Velard, F., and Gangloff, S.C. (2015). Staphylococcus aureus vs. osteoblast: Relationship and consequences in osteomyelitis. Front. Cell Infect. Microbiol., 5.","DOI":"10.3389\/fcimb.2015.00085"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"e02447-19","DOI":"10.1128\/mBio.02447-19","article-title":"Staphylococcus aureus infects osteoclasts and replicates intracellularly","volume":"10","author":"Krauss","year":"2019","journal-title":"mBio"},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Tricou, L.P., Mouton, W., Cara, A., Trouillet-Assant, S., Bouvard, D., Laurent, F., Diot, A., and Josse, J. (2024). Staphylococcus aureus can use an alternative pathway to be internalized by osteoblasts in absence of \u03b21 integrins. Sci. Rep., 14.","DOI":"10.1038\/s41598-024-78754-z"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1042\/EBC20160056","article-title":"Innovative approaches to treat Staphylococcus aureus biofilm-related infections","volume":"61","author":"Richter","year":"2017","journal-title":"Essay Biochem."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1111\/j.1749-6632.2011.06281.x","article-title":"New approaches for treating staphylococcal biofilm infections","volume":"1241","author":"Kiedrowski","year":"2011","journal-title":"Ann. N.Y. Acad. Sci."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1007\/s40273-021-01065-y","article-title":"2021. How much does it cost to research and develop a new drug? A systematic review and assessment","volume":"39","author":"Schlander","year":"2021","journal-title":"Pharmacoeconomics"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.2217\/fmb.13.92","article-title":"An insight into pleiotropic regulators Agr and Sar: Molecular probes paving the new way for antivirulent therapy","volume":"8","author":"Arya","year":"2013","journal-title":"Future Microbiol."},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Arya, R., Ravikumar, R., Santhosh, R.S., and Princy, S.A. (2015). SarA based novel therapeutic candidate against Staphylococcus aureus associated with vascular graft infections. Front. Microbiol., 6.","DOI":"10.3389\/fmicb.2015.00416"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.2174\/0929867324666171121102829","article-title":"High-throughput screening strategies for the development of anti-virulence inhibitors against Staphylococcus aureus","volume":"26","author":"Cai","year":"2019","journal-title":"Curr. Med. Chem."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1021\/jm3014635","article-title":"Attenuating Staphylococcus aureus virulence gene regulation: A medicinal chemistry perspective","volume":"56","author":"Gordon","year":"2013","journal-title":"J. Med. Chem."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1080\/14787210.2023.2242585","article-title":"Understanding mechanisms of virulence in MRSA: Implications for antivirulence treatment strategies","volume":"21","author":"Hsieh","year":"2023","journal-title":"Expert Rev. Anti Infect. Ther."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"2705","DOI":"10.1021\/acs.jmedchem.9b00798","article-title":"Structure-activity relationship studies of small molecule modulators of the staphylococcal accessory gene regulator","volume":"63","author":"Horswill","year":"2020","journal-title":"J Med. Chem."},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Otto, M. (2023). Critical assessment of the prospects of quorum-quenching therapy for Staphylococcus aureus infection. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24044025"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1080\/14787210.2020.1750951","article-title":"Alternative approaches to treat bacterial infections: Targeting quorum-sensing","volume":"18","author":"Piewngam","year":"2020","journal-title":"Expert Rev. Anti Infect. Ther."},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Sully, E.K., Malachowa, N., Elmore, B.O., Alexander, S.M., Femling, J.K., Gray, B.M., DeLeo, F.R., Otto, M., Cheung, A.L., and Edwards, B.S. (2014). Selective chemical inhibition of agr quorum sensing in Staphylococcus aureus promotes host defense with minimal impact on resistance. PLoS Pathog., J10.","DOI":"10.1371\/journal.ppat.1004174"},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Tan, L., Li, S.R., Jiang, B., Hu, X.M., and Li, S. (2018). Therapeutic targeting of the Staphylococcus aureus accessory gene regulator (agr) system. Front. Microbiol., 9.","DOI":"10.3389\/fmicb.2018.00055"},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Vinodhini, V., and Kavitha, M. (2024). Deciphering agr quorum sensing in Staphylococcus aureus: Insights and therapeutic prospects. Mol. Biol. Rep., 51.","DOI":"10.1007\/s11033-023-08930-3"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"e0047324","DOI":"10.1128\/iai.00473-24","article-title":"The ability of sarA to limit protease production plays a key role in the pathogenesis of Staphylococcus aureus osteomyelitis irrespective of the functional status of agr","volume":"93","author":"Beenken","year":"2025","journal-title":"Infect. Immun."},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Campbell, M.J., Beenken, K.E., Ramirez, A.M., and Smeltzer, M.S. (2024). Increased production of aureolysin and staphopain A is a primary determinant of the reduced virulence of Staphylococcus aureus sarA mutants in osteomyelitis. mBio, 15.","DOI":"10.1128\/mbio.03383-23"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"3373","DOI":"10.1128\/iai.63.9.3373-3380.1995","article-title":"Role of the accessory gene regulator (agr) in pathogenesis of staphylococcal osteomyelitis","volume":"63","author":"Gillaspy","year":"1995","journal-title":"Infect. Immun."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"2586","DOI":"10.1128\/IAI.00152-16","article-title":"Impact of sarA and phenol-soluble modulins on the pathogenesis of osteomyelitis in diverse clinical isolates of Staphylococcus aureus","volume":"84","author":"Loughran","year":"2016","journal-title":"Infect. Immun."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1080\/21505594.2017.1373926","article-title":"Impact of Staphylococcus aureus regulatory mutations that modulate biofilm formation in the USA300 strain LAC on virulence in a murine bacteremia model","volume":"8","author":"Rom","year":"2017","journal-title":"Virulence"},{"key":"ref_57","doi-asserted-by":"crossref","unstructured":"Beenken, K.E., Campbell, M.J., Byrum, S.D., Edmondson, R.D., Mackintosh, S.G., Tackett, A.J., and Smeltzer, M.S. (2025). Staphylococcus aureus proteins implicated in the reduced virulence of sarA and sarA\/agr mutants in osteomyelitis. Microorganisms., 13.","DOI":"10.3390\/microorganisms13010181"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1056\/NEJM199808203390806","article-title":"Staphylococcus aureus infections","volume":"339","author":"Lowy","year":"1998","journal-title":"N. Engl. J. Med."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"4847","DOI":"10.1093\/nar\/gku119","article-title":"Dual RNA regulatory control of a Staphylococcus aureus virulence factor","volume":"42","author":"Chabelskaya","year":"2014","journal-title":"Nucleic Acids Res."},{"key":"ref_60","doi-asserted-by":"crossref","unstructured":"Chevalier, C., Boisset, S., Romilly, C., Masquida, B., Fechter, P., Geissmann, T., Vandenesch, F., and Romby, P. (2010). Staphylococcus aureus RNAIII binds to two distant regions of coa mRNA to arrest translation and promote mRNA degradation. PLoS Pathog., 6.","DOI":"10.1371\/journal.ppat.1000809"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"4569","DOI":"10.1002\/j.1460-2075.1995.tb00136.x","article-title":"Activation of alpha-toxin translation in Staphylococcus aureus by the trans-encoded antisense RNA, RNAIII","volume":"14","author":"Morfeldt","year":"1995","journal-title":"EMBO J."},{"key":"ref_62","doi-asserted-by":"crossref","unstructured":"Chatterjee, S.S., Chen, L., Joo, H.S., Cheung, G.Y., Kreiswirth, B.N., and Otto, M. (2011). Distribution and regulation of the mobile genetic element-encoded phenol-soluble modulin PSM-mec in methicillin-resistant Staphylococcus aureus. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0028781"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"37169","DOI":"10.1074\/jbc.274.52.37169","article-title":"SarA a global regulator of virulence determinants in Staphylococcus aureus, binds to a conserved motif essential for sar-dependent gene regulation","volume":"274","author":"Chien","year":"1999","journal-title":"J. Bi. Chem."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1046\/j.1365-2958.1998.01126.x","article-title":"SarA level is a determinant of agr activation in Staphylococcus aureus","volume":"30","author":"Chien","year":"1998","journal-title":"Mol. Microbiol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"3963","DOI":"10.1128\/jb.179.12.3963-3971.1997","article-title":"sar genetic determinants necessary for transcription of RNAII and RNAIII in the agr locus of Staphylococcus aureus","volume":"179","author":"Cheung","year":"1997","journal-title":"J. Bacteriol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"4168","DOI":"10.1128\/jb.176.13.4168-4172.1994","article-title":"Cloning and sequencing of sarA of Staphylococcus aureus, a gene required for the expression of agr","volume":"176","author":"Cheung","year":"1994","journal-title":"J. Bacteriol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"4206","DOI":"10.1128\/IAI.71.7.4206-4211.2003","article-title":"Mutation of sarA in Staphylococcus aureus limits biofilm formation","volume":"71","author":"Beenken","year":"2003","journal-title":"Infect. Immun."},{"key":"ref_68","doi-asserted-by":"crossref","unstructured":"Beenken, K.E., Mrak, L.N., Griffin, L.M., Zielinska, A.K., Shaw, L.N., Rice, K.C., Horswill, A.R., Bayles, K.W., and Smeltzer, M.S. (2010). Epistatic relationships between sarA and agr in Staphylococcus aureus biofilm formation. PLoS ONE, 5.","DOI":"10.1371\/journal.pone.0010790"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"e00331-18","DOI":"10.1128\/IAI.00331-18","article-title":"Genome plasticity of agr-defective Staphylococcus aureus during clinical infection","volume":"86","author":"Altman","year":"2018","journal-title":"Infect. Immun."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"e00796-19","DOI":"10.1128\/mBio.00796-19","article-title":"Finding of agr phase variants in Staphylococcus aureus","volume":"10","author":"Gor","year":"2019","journal-title":"mBio"},{"key":"ref_71","doi-asserted-by":"crossref","unstructured":"Suligoy, C.M., Lattar, S.M., Noto Llana, M., Gonz\u00e1lez, C.D., Alvarez, L.P., Robinson, D.A., G\u00f3mez, M.I., Buzzola, F.R., and Sordelli, D.O. (2018). Mutation of agr is associated with the adaptation of Staphylococcus aureus to the host during chronic osteomyelitis. Front. Cell Infect. Microbiol., 8.","DOI":"10.3389\/fcimb.2018.00018"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1099\/mic.0.2007\/011874-0","article-title":"agr function in clinical Staphylococcus aureus isolates","volume":"154","author":"Traber","year":"2008","journal-title":"Microbiology (Reading)"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1093\/infdis\/jis483","article-title":"Nasal carriage as a source of agr-defective Staphylococcus aureus bacteremia","volume":"206","author":"Smyth","year":"2012","journal-title":"J. Infect. Dis."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"7961","DOI":"10.1128\/JB.00789-07","article-title":"Generation of virulence factor variants in Staphylococcus aureus biofilms","volume":"189","author":"Yarwood","year":"2007","journal-title":"J. Bacteriol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"4096","DOI":"10.1128\/AAC.00484-09","article-title":"Impact of sarA on daptomycin susceptibility of Staphylococcus aureus biofilms in vivo","volume":"53","author":"Weiss","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.1128\/AAC.01432-08","article-title":"Impact of sarA on antibiotic susceptibility of Staphylococcus aureus in a catheter-associated in vitro model of biofilm formation","volume":"53","author":"Weiss","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.ijantimicag.2009.01.018","article-title":"sarA inactivation reduces vancomycin-intermediate and ciprofloxacin resistance expression by Staphylococcus aureus","volume":"34","author":"Cantore","year":"2009","journal-title":"Int. J. Antimicrob. Agents."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"5171","DOI":"10.1128\/JB.183.17.5171-5179.2001","article-title":"Influence of a functional sigB operon on the global regulators sar and agr in Staphylococcus aureus","volume":"183","author":"Bischoff","year":"2001","journal-title":"J. Bacteriol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"4239","DOI":"10.1128\/IAI.70.8.4239-4246.2002","article-title":"Variation in extracellular protease production among clinical isolates of Staphylococcus aureus due to different levels of expression of the protease repressor sarA","volume":"70","author":"Karlsson","year":"2002","journal-title":"Infect. Immun."},{"key":"ref_80","doi-asserted-by":"crossref","unstructured":"Tuchscherr, L., Bischoff, M., Lattar, S.M., Noto Llana, M., Pf\u00f6rtner, H., Niemann, S., Geraci, J., Van de Vyver, H., Fraunholz, M.J., and Cheung, A.L. (2015). Sigma factor SigB is crucial to mediate Staphylococcus aureus adaptation during chronic infections. PLoS Pathog., 11.","DOI":"10.1371\/journal.ppat.1004870"},{"key":"ref_81","doi-asserted-by":"crossref","unstructured":"Tuchscherr, L., Geraci, J., and L\u00f6ffler, B. (2017). Staphylococcus aureus regulator sigma B is important to develop chronic infections in hematogenous murine osteomyelitis model. Pathogens., 6.","DOI":"10.3390\/pathogens6030031"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.ijantimicag.2006.01.013","article-title":"Contributions of sigB and sarA to distinct multiple antimicrobial resistance mechanisms of Staphylococcus aureus","volume":"28","author":"Riordan","year":"2006","journal-title":"Int. J. Antimicrob. Agents."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s00294-015-0503-0","article-title":"Staphylococcus aureus dynamically adapts global regulators and virulence factor expression in the course from acute to chronic infection","volume":"62","author":"Tuchscherr","year":"2016","journal-title":"Curr. Genet."},{"key":"ref_84","doi-asserted-by":"crossref","unstructured":"Tuchscherr, L., L\u00f6ffler, B., and Proctor, R.A. (2020). Persistence of Staphylococcus aureus: Multiple metabolic pathways impact the expression of virulence factors in small-colony variants (SCVs). Front. Microbiol., 11.","DOI":"10.3389\/fmicb.2020.01028"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1002\/cmdc.202000677","article-title":"Therapeutic strategies to counteract antibiotic resistance in MRSA biofilm-associated infections","volume":"16","author":"Cascioferro","year":"2021","journal-title":"ChemMedChem."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"e00468-20","DOI":"10.1128\/AAC.00468-20","article-title":"The emerging role of \u03b2-Lactams in the treatment of methicillin-resistant Staphylococcus aureus bloodstream infections","volume":"64","author":"Molina","year":"2020","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1093\/infdis\/jiw386","article-title":"The global regulon sarA regulates \u03b2-lactam antibiotic resistance in methicillin-resistant Staphylococcus aureus in vitro and in endovascular infections","volume":"214","author":"Li","year":"2016","journal-title":"J. Infect. Dis."},{"key":"ref_88","first-page":"117","article-title":"New advances in antibiotic development and discovery. Expert Opin","volume":"14","author":"Alekshun","year":"2005","journal-title":"Investig. Drugs."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.bcp.2016.10.001","article-title":"History of antimicrobial drug discovery: Major classes and health impact","volume":"133","author":"Aminov","year":"2017","journal-title":"Biochem. Pharmacol."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/s41579-019-0293-3","article-title":"Antibiotic development\u2014economic, regulatory and societal challenges","volume":"18","author":"Balasegaram","year":"2020","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_91","doi-asserted-by":"crossref","unstructured":"Wang, C.H., Hsieh, Y.H., Powers, Z.M., and Kao, C.Y. (2020). Defeating antibiotic-resistant bacteria: Exploring alternative therapies for a post-antibiotic era. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21031061"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1128\/JCM.38.3.1008-1015.2000","article-title":"Multilocus sequence typing for characterization of methicillin-resistant and methicillin-susceptible clones of Staphylococcus aureus","volume":"38","author":"Enright","year":"2000","journal-title":"J. Clin. Microbiol."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1038\/nrmicro2200","article-title":"Waves of resistance: Staphylococcus aureus in the antibiotic era","volume":"7","author":"Chambers","year":"2009","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.3201\/eid2111.150452","article-title":"USA300 methicillin-resistant Staphylococcus aureus, United States, 2000\u20132013","volume":"21","author":"Carrel","year":"2015","journal-title":"Emerg. Infect. Dis."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"e00537-12","DOI":"10.1128\/mBio.00537-12","article-title":"A genetic resource for rapid and comprehensive phenotype screening of nonessential Staphylococcus aureus genes","volume":"4","author":"Fey","year":"2013","journal-title":"mBio"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1128\/JB.187.2.576-592.2005","article-title":"Comparative genomics of Staphylococcus aureus musculoskeletal isolates","volume":"187","author":"Cassat","year":"2005","journal-title":"J. Bacteriol."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S8756-3282(01)00632-9","article-title":"Staphylococcus aureus collagen adhesin contributes to the pathogenesis of osteomyelitis","volume":"30","author":"Elasri","year":"2002","journal-title":"Bone"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1128\/IAI.00364-10","article-title":"Essential role for the major autolysin in the fibronectin-binding protein-mediated Staphylococcus aureus biofilm phenotype","volume":"79","author":"Houston","year":"2011","journal-title":"Infect. Immun."},{"key":"ref_99","doi-asserted-by":"crossref","unstructured":"Kaushik, A., Kest, H., Sood, M., Steussy, B.W., Thieman, C., and Gupta, S. (2024). Biofilm producing methicillin-rsistant Staphylococcus aureus (MRSA) infections in humans: Clinical implications and management. Pathogens, 13.","DOI":"10.3390\/pathogens13010076"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1111\/j.1365-2958.1990.tb02044.x","article-title":"Cryptic alpha-toxin gene in toxic shock syndrome and septicaemia strains of Staphylococcus aureus","volume":"4","author":"Kreiswirth","year":"1990","journal-title":"Mol. Microbiol."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"3214","DOI":"10.1128\/JB.185.10.3214-3217.2003","article-title":"Alpha-toxin is required for biofilm formation by Staphylococcus aureus","volume":"185","author":"Caiazza","year":"2003","journal-title":"J. Bacteriol."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1080\/21505594.2021.1879550","article-title":"Limiting protease production plays a key role in the pathogenesis of the divergent clinical isolates of Staphylococcus aureus LAC and UAMS-1","volume":"12","author":"Rom","year":"2021","journal-title":"Virulence"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1128\/JB.01000-07","article-title":"Genome sequence of Staphylococcus aureus strain Newman and comparative analysis of staphylococcal genomes: Polymorphism and evolution of two major pathogenicity islands","volume":"190","author":"Baba","year":"2008","journal-title":"J. Bacteriol."},{"key":"ref_104","doi-asserted-by":"crossref","unstructured":"Carpaij, N., Willems, R.J., Rice, T.W., Weinstein, R.A., Hinds, J., Witney, A.A., Lindsay, J.A., Bonten, M.J., and Fluit, A.C. (2011). Genetic variation in spatio-temporal confined USA300 community-associated MRSA isolates: A shift from clonal dispersion to genetic evolution?. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0016419"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/S0140-6736(06)68231-7","article-title":"Complete genome sequence of USA300, an epidemic clone of community-acquired meticillin-resistant Staphylococcus aureus","volume":"367","author":"Diep","year":"2006","journal-title":"Lancet"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"4504","DOI":"10.1128\/JCM.01050-10","article-title":"Complete nucleotide sequence analysis of plasmids in strains of Staphylococcus aureus clone USA300 reveals a high level of identity among isolates with closely related core genome sequences","volume":"48","author":"Kennedy","year":"2010","journal-title":"J. Clin. Microbiol."},{"key":"ref_107","doi-asserted-by":"crossref","unstructured":"Tewhey, R., Cannavino, C.R., Leake, J.A., Bansal, V., Topol, E.J., Torkamani, A., Bradley, J.S., and Schork, N.J. (2012). Genetic structure of community acquired methicillin-resistant Staphylococcus aureus USA300. BMC Genomics., 13.","DOI":"10.1186\/1471-2164-13-508"},{"key":"ref_108","doi-asserted-by":"crossref","unstructured":"Sassi, M., Sharma, D., Brinsmade, S.R., Felden, B., and Augagneur, Y. (2015). Genome sequence of the clinical isolate Staphylococcus aureus subsp. aureus strain UAMS-1. Genome Announc., 3.","DOI":"10.1128\/genomeA.01584-14"},{"key":"ref_109","doi-asserted-by":"crossref","unstructured":"Hern\u00e1ndez-Cuellar, E., Tsuchiya, K., Valle-R\u00edos, R., and Medina-Contreras, O. (2023). Differences in biofilm formation by methicillin-resistant and methicillin-susceptible Staphylococcus aureus strains. Diseases, 11.","DOI":"10.3390\/diseases11040160"},{"key":"ref_110","doi-asserted-by":"crossref","unstructured":"McCarthy, H., Rudkin, J.K., Black, N.S., Gallagher, L., O\u2019Neill, E., and O\u2019Gara, J.P. (2015). Methicillin resistance and the biofilm phenotype in Staphylococcus aureus. Front. Cell Infect. Microbiol., 5.","DOI":"10.3389\/fcimb.2015.00001"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1128\/JCM.02280-06","article-title":"Association between methicillin susceptibility and biofilm regulation in Staphylococcus aureus isolates from device-related infections","volume":"45","author":"Pozzi","year":"2007","journal-title":"J. Clin. Microbiol."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1002\/mbo3.214","article-title":"Impact of individual extracellular proteases on Staphylococcus aureus biofilm formation in diverse clinical isolates and their isogenic sarA mutants","volume":"3","author":"Loughran","year":"2014","journal-title":"Microbiologyopen"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1111\/mmi.12629","article-title":"Impact of the functional status of saeRS on in vivo phenotypes of Staphylococcus aureus\u2005sarA mutants","volume":"92","author":"Beenken","year":"2014","journal-title":"Mol. Microbiol."},{"key":"ref_114","doi-asserted-by":"crossref","unstructured":"Mrak, L.N., Zielinska, A.K., Beenken, K.E., Mrak, I.N., Atwood, D.N., Griffin, L.M., Lee, C.Y., and Smeltzer, M.S. (2012). saeRS and sarA act synergistically to repress protease production and promote biofilm formation in Staphylococcus aureus. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0038453"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1021\/acsinfecdis.9b00291","article-title":"Exploiting correlations between protein abundance and the functional status of saeRS and sarA to identify virulence factors of potential importance in the pathogenesis of Staphylococcus aureus osteomyelitis","volume":"6","author":"Ramirez","year":"2020","journal-title":"ACS Infect. Dis."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.ijmm.2006.01.067","article-title":"Natural human isolates of Staphylococcus aureus selected for high production of proteases and alpha-hemolysin are sigmaB deficient","volume":"296","author":"Arvidson","year":"2006","journal-title":"Int. J. Med. Microbiol."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"2877","DOI":"10.1128\/IAI.00088-10","article-title":"Repair of global regulators in Staphylococcus aureus 8325 and comparative analysis with other clinical isolates","volume":"78","author":"Herbert","year":"2010","journal-title":"Infect. Immun."},{"key":"ref_118","doi-asserted-by":"crossref","unstructured":"Le, K.Y., Dastgheyb, S., Ho, T.V., and Otto, M. (2014). Molecular determinants of staphylococcal biofilm dispersal and structuring. Front. Cell Infect. Microbiol., 4.","DOI":"10.3389\/fcimb.2014.00167"},{"key":"ref_119","doi-asserted-by":"crossref","unstructured":"DelMain, E.A., Moormeier, D.E., Endres, J.L., Hodges, R.E., Sadykov, M.R., Horswill, A.R., and Bayles, K.W. (2020). Stochastic expression of sae-dependent virulence genes during Staphylococcus aureus biofilm development is dependent on SaeS. mBio, 11.","DOI":"10.1128\/mBio.03081-19"},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"7155","DOI":"10.1128\/IAI.72.12.7155-7163.2004","article-title":"Truncation of fibronectin-binding proteins in Staphylococcus aureus strain Newman leads to deficient adherence and host cell invasion due to loss of the cell wall anchor function","volume":"72","author":"Grundmeier","year":"2004","journal-title":"Infect. Immun."},{"key":"ref_121","doi-asserted-by":"crossref","unstructured":"Cue, D., Junecko, J.M., Lei, M.G., Blevins, J.S., Smeltzer, M.S., and Lee, C.Y. (2015). SaeRS-dependent inhibition of biofilm formation in Staphylococcus aureus Newman. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0123027"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1080\/21505594.2020.1855923","article-title":"2020. SarA plays a predominant role in controlling the production of extracellular proteases in diverse clinical isolates of Staphylococcus aureus","volume":"11","author":"Ramirez","year":"2020","journal-title":"Virulence"},{"key":"ref_123","doi-asserted-by":"crossref","unstructured":"Tsang, L.H., Cassat, J.E., Shaw, L.N., Beenken, K., and Smeltzer, M.S. (2008). Factors contributing to the biofilm-deficient phenotype of Staphylococcus aureus sarA mutants. PLoS ONE, 3.","DOI":"10.1371\/journal.pone.0003361"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1111\/mmi.12048","article-title":"sarA-mediated repression of protease production plays a key role in the pathogenesis of Staphylococcus aureus USA300 isolates","volume":"86","author":"Zielinska","year":"2012","journal-title":"Mol. Microbiol."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1128\/IAI.06134-11","article-title":"Impact of extracellular nuclease production on the biofilm phenotype of Staphylococcus aureus under in vitro and in vivo conditions","volume":"80","author":"Beenken","year":"2012","journal-title":"Infect. Immun."},{"key":"ref_126","doi-asserted-by":"crossref","unstructured":"Sugimoto, S., Sato, F., Miyakawa, R., Chiba, A., Onodera, S., Hori, S., and Mizunoe, Y. (2018). Broad impact of extracellular DNA on biofilm formation by clinically isolated Methicillin-resistant and -sensitive strains of Staphylococcus aureus. Sci. Rep., 8.","DOI":"10.1038\/s41598-018-20485-z"},{"key":"ref_127","doi-asserted-by":"crossref","unstructured":"Gries, C.M., Biddle, T., Bose, J.L., Kielian, T., and Lo, D.D. (2020). Staphylococcus aureus fibronectin binding protein A mediates biofilm development and infection. Infect. Immun., 88.","DOI":"10.1128\/IAI.00859-19"},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1128\/JB.01222-08","article-title":"Protein A-mediated multicellular behavior in Staphylococcus aureus","volume":"191","author":"Merino","year":"2009","journal-title":"J. Bacteriol."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"8821","DOI":"10.1073\/pnas.161098098","article-title":"Evolutionary genomics of Staphylococcus aureus: Insights into the origin of methicillin-resistant strains and the toxic shock syndrome epidemic","volume":"98","author":"Fitzgerald","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"3384","DOI":"10.1021\/acs.jproteome.8b00288","article-title":"Label-free proteomic approach to characterize protease-dependent and independent effects of sarA inactivation on the Staphylococcus aureus exoproteome","volume":"17","author":"Byrum","year":"2018","journal-title":"ACS J. Proteome Res."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1007\/s00011-023-01745-9","article-title":"Staphylococci planktonic and biofilm environments differentially affect osteoclast formation","volume":"72","author":"Seebach","year":"2023","journal-title":"Inflamm. Res."},{"key":"ref_132","doi-asserted-by":"crossref","unstructured":"Mouton, W., Josse, J., Jacqueline, C., Abad, L., Trouillet-Assant, S., Caillon, J., Bouvard, D., Bouchet, M., Laurent, F., and Diot, A. (2021). Staphylococcus aureus internalization impairs osteoblastic activity and early differentiation process. Sci. Rep., 11.","DOI":"10.1038\/s41598-021-97246-y"},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"e0114022","DOI":"10.1128\/aac.01140-22","article-title":"Neutralization of Staphylococcus aureus protein A prevents exacerbated osteoclast activity and bone loss during osteomyelitis","volume":"67","author":"Gehrke","year":"2023","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"117181","DOI":"10.1016\/j.bone.2024.117181","article-title":"RANKL-mediated osteoclast formation is required for bone loss in a murine model of Staphylococcus aureus osteomyelitis","volume":"187","author":"Campbell","year":"2024","journal-title":"Bone"},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"3713","DOI":"10.4049\/jimmunol.164.7.3713","article-title":"Survival of Staphylococcus aureus inside neutrophils contributes to infection","volume":"164","author":"Gresham","year":"2000","journal-title":"J. Immunol."},{"key":"ref_136","doi-asserted-by":"crossref","unstructured":"Kubica, M., Guzik, K., Koziel, J., Zarebski, M., Richter, W., Gajkowska, B., Golda, A., Maciag-Gudowska, A., Brix, K., and Shaw, L. (2008). A potential new pathway for Staphylococcus aureus dissemination: The silent survival of S. aureus phagocytosed by human monocyte-derived macrophages. PLoS ONE, 3.","DOI":"10.1371\/journal.pone.0001409"},{"key":"ref_137","doi-asserted-by":"crossref","unstructured":"Rasigade, J.P., Trouillet-Assant, S., Ferry, T., Diep, B.A., Sapin, A., Lhoste, Y., Ranfaing, J., Badiou, C., Benito, Y., and Bes, M. (2013). PSMs of hypervirulent Staphylococcus aureus act as intracellular toxins that kill infected osteoblasts. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0063176"},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/j.ijmm.2014.07.013","article-title":"Staphylococcus aureus isolates from chronic osteomyelitis are characterized by high host cell invasion and intracellular adaptation, but still induce inflammation","volume":"304","author":"Kalinka","year":"2014","journal-title":"Int. J. Med. Microbiol."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1046\/j.1462-5822.2001.00157.x","article-title":"Fibronectin-binding protein A of Staphylococcus aureus has multiple, substituting, binding regions that mediate adherence to fibronectin and invasion of endothelial cells","volume":"3","author":"Massey","year":"2001","journal-title":"Cell Microbiol."},{"key":"ref_140","doi-asserted-by":"crossref","unstructured":"Niemann, S., Nguyen, M.T., Eble, J.A., Chasan, A.I., Mrakovcic, M., B\u00f6ttcher, R.T., Preissner, K.T., Ro\u00dflenbroich, S., Peters, G., and Herrmann, M. (2021). More is not always better-the double-headed role of fibronectin in Staphylococcus aureus host cell invasion. mBio, 12.","DOI":"10.1128\/mBio.01062-21"},{"key":"ref_141","doi-asserted-by":"crossref","unstructured":"Speziale, P., and Pietrocola, G. (2020). The multivalent role of fibronectin-binding proteins A and B (FnBPA and FnBPB) of Staphylococcus aureus in host infections. Front. Microbiol., 11.","DOI":"10.3389\/fmicb.2020.02054"},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"e0041823","DOI":"10.1128\/jb.00418-23","article-title":"Crosstalk involving two-component systems in Staphylococcus aureus signaling networks","volume":"206","author":"Ali","year":"2024","journal-title":"J.Bacteriol."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"100137","DOI":"10.1016\/j.tcsw.2024.100137","article-title":"Staphylococcus aureus: Current perspectives on molecular pathogenesis and virulence","volume":"13","author":"Girma","year":"2024","journal-title":"Cell Surf."},{"key":"ref_144","doi-asserted-by":"crossref","unstructured":"Patel, H., and Rawat, S. (2023). A genetic regulatory see-saw of biofilm and virulence in MRSA pathogenesis. Front. Microbiol., 14.","DOI":"10.3389\/fmicb.2023.1204428"},{"key":"ref_145","doi-asserted-by":"crossref","unstructured":"Peng, Q., Tang, X., Dong, W., Sun, N., and Yuan, W. (2022). A review of biofilm formation of Staphylococcus aureus and its regulation mechanism. Antibiotics, 12.","DOI":"10.3390\/antibiotics12010012"},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.chom.2013.05.003","article-title":"A secreted bacterial protease tailors the Staphylococcus aureus virulence repertoire to modulate bone remodeling during osteomyelitis","volume":"13","author":"Cassat","year":"2013","journal-title":"Cell Host Microbe."},{"key":"ref_147","doi-asserted-by":"crossref","unstructured":"Gimza, B.D., Larias, M.I., Budney, B.G., and Shaw, L.N. (2019). Mapping the global network of extracellular protease regulation in Staphylococcus aureus. mSphere, 4.","DOI":"10.1128\/mSphere.00676-19"},{"key":"ref_148","doi-asserted-by":"crossref","unstructured":"Gimza, B.D., Jackson, J.K., Frey, A.M., Budny, B.G., Chaput, D., Rizzo, D.N., and Shaw, L.N. (2021). Unraveling the impact of secreted proteases on hyprevirulence in Staphylococcus aureus. mBio, 12.","DOI":"10.1128\/mBio.03288-20"},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1099\/mic.0.26634-0","article-title":"The role and regulation of the extracellular proteases of Staphylococcus aureus","volume":"150","author":"Shaw","year":"2004","journal-title":"Microbiology"},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"4410","DOI":"10.1128\/JB.185.15.4410-4417.2003","article-title":"Characterization of Staphylococcus aureus SarA binding sites","volume":"185","author":"Sterba","year":"2003","journal-title":"J. Bacteriol."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1128\/IAI.01462-15","article-title":"XerC contributes to diverse forms of Staphylococcus aureus infection via agr-dependent and agr-independent pathways","volume":"84","author":"Atwood","year":"2016","journal-title":"Infect. Immun."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"e0120622","DOI":"10.1128\/aac.01206-22","article-title":"XerC is required for the repair of antibiotic- and immune-mediated DNA damage in Staphylococcus aureus","volume":"67","author":"Ledger","year":"2023","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_153","doi-asserted-by":"crossref","unstructured":"Ushijima, Y., Ohniwa, R.L., and Morikawa, K. (2017). Identification of nucleoid associated proteins (NAPs) under oxidative stress in Staphylococcus aureus. BMC Microbiol., 17.","DOI":"10.1186\/s12866-017-1114-3"},{"key":"ref_154","doi-asserted-by":"crossref","unstructured":"Fujimoto, D.F., Higginbotham, R.H., Sterba, K.M., Maleki, S.J., Segall, A.M., Smeltzer, M.S., and Hurlburt, B.K. (2009). Staphylococcus aureus SarA is a regulatory protein responsive to redox and pH that can support bacteriophage lambda integrase-mediated excision\/recombination. Mol. Microbiol., 74.","DOI":"10.1111\/j.1365-2958.2009.06942.x"},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"e0013822","DOI":"10.1128\/jb.00138-22","article-title":"Functional mgrA influences genetic changes within a Staphylococcus aureus cell population over time","volume":"204","author":"Lee","year":"2022","journal-title":"J. Bacteriol."},{"key":"ref_156","doi-asserted-by":"crossref","unstructured":"Goncheva, M.I., Flannagan, R.S., and Heinrichs, D.E. (2020). De novo purine biosynthesis is required for intracellular growth of Staphylococcus aureus and for the hypervirulence phenotype of a purR mutant. Infect. Immun., 88.","DOI":"10.1128\/IAI.00104-20"},{"key":"ref_157","doi-asserted-by":"crossref","unstructured":"Alkam, D., Jenjaroenpunb, P., Ramirez, A.M., Spencer, H.J., and Smeltzer, M.S. (2021). The increased accumulation of Staphylococcus aureus virulence factors is maximized in a purR mutant by the increased production of SarA and decreased production of extracellular proteases. Infect. Immun., 89.","DOI":"10.1128\/IAI.00718-20"},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1093\/infdis\/jiad577","article-title":"The purine biosynthesis repressor, PurR, contributes to vancomycin susceptibility of methicillin-resistant Staphylococcus aureus in experimental endocarditis","volume":"229","author":"Xiong","year":"2024","journal-title":"J. Infect. Dis."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1111\/mmi.12943","article-title":"Rot is a key regulator of Staphylococcus aureus biofilm formation","volume":"96","author":"Mootz","year":"2015","journal-title":"Mol. Microbiol."},{"key":"ref_160","doi-asserted-by":"crossref","unstructured":"Guo, X., Wang, L., Zhang, J., Liu, Q., Wang, B., Liu, D., Gao, F., Lanzi, G., Zhao, Y., and Shi, Y. (2024). Thwarting resistance: MgrA inhibition with methylophiopogonanone a unveils a new battlefront against S. aureus. NPJ Biofilms Microbiomes, 10.","DOI":"10.1038\/s41522-024-00485-w"},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"2559","DOI":"10.1099\/mic.0.29071-0","article-title":"Identification and characterization of msa (SA1233), a gene involved in expression of sarA and several virulence factors in Staphylococcus aureus","volume":"152","author":"Sambanthamoorthy","year":"2006","journal-title":"Microbiology"},{"key":"ref_162","doi-asserted-by":"crossref","unstructured":"Sambanthamoorthy, K., Schwartz, A., Nagarajan, V., and Elasri, M.O. (2008). The role of msa in Staphylococcus aureus biofilm formation. BMC Microbiol., 8.","DOI":"10.1186\/1471-2180-8-221"},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1099\/mic.0.000243","article-title":"MsaB activates capsule production at the transcription level in Staphylococcus aureus","volume":"162","author":"Batte","year":"2016","journal-title":"Microbiology"},{"key":"ref_164","doi-asserted-by":"crossref","unstructured":"Pandey, S., Sahukhal, G.S., and Elasri, M.O. (2021). The msaABCR operon regulates persister formation by modulating energy metabolism in Staphylococcus aureus. Front. Microbiol., 12.","DOI":"10.3389\/fmicb.2021.657753"},{"key":"ref_165","doi-asserted-by":"crossref","unstructured":"Sahukhal, G.S., and Elasri, M.O. (2019). Role of the msaABCR operon in cell wall biosynthesis, autolysis, integrity, and antibiotic resistance in Staphylococcus aureus. Antimicrob. Agents Chemother., 63.","DOI":"10.1128\/AAC.00680-19"},{"key":"ref_166","doi-asserted-by":"crossref","unstructured":"Sahukhal, G.S., Tucci, M., Benghuzzi, H., Wilson, G., and Elasri, M.O. (2020). The role of the msaABCR operon in implant-associated chronic osteomyelitis in Staphylococcus aureus USA300 LAC. BMC Microbiol., 20.","DOI":"10.1186\/s12866-020-01964-8"},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"2871","DOI":"10.1128\/IAI.66.6.2871-2878.1998","article-title":"Characterization of a sar homolog of Staphylococcus epidermidis","volume":"66","author":"Fluckiger","year":"1998","journal-title":"Infect. Immun."},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.1128\/JB.187.7.2348-2356.2005","article-title":"SarA is an essential positive regulator of Staphylococcus epidermidis biofilm development","volume":"187","author":"Tormo","year":"2005","journal-title":"J. Bacteriol."},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1111\/j.1365-2958.2012.08203.x","article-title":"sarA negatively regulates Staphylococcus epidermidis biofilm formation by modulating expression of 1\u2009MDa extracellular matrix binding protein and autolysis-dependent release of eDNA","volume":"86","author":"Christner","year":"2012","journal-title":"Mol. Microbiol."},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1128\/IAI.71.1.516-523.2003","article-title":"Role of sarA in the pathogenesis of Staphylococcus aureus musculoskeletal infection","volume":"71","author":"Blevins","year":"2003","journal-title":"Infect. Immun."},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1128\/iai.65.4.1550-1556.1997","article-title":"Staphylococcal accessory regulator (sar) in conjunction with agr contributes to Staphylococcus aureus virulence in endophthalmitis","volume":"65","author":"Booth","year":"1997","journal-title":"Infect. Immun."},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1128\/IAI.70.1.127-133.2002","article-title":"Staphylococcus aureus agr and sarA functions are required for invasive infection but not inflammatory responses in the lung","volume":"70","author":"Heyer","year":"2002","journal-title":"Infect. Immun."},{"key":"ref_173","doi-asserted-by":"crossref","unstructured":"Elmwall, J., Kwiecinski, J., Na, M., Ali, A.A., Osla, V., Shaw, L.N., Wang, W., S\u00e4vman, K., Josefsson, E., and Bylund, J. (2017). Galectin-3 is a target for proteases involved in the virulence of Staphylococcus aureus. Infect. Immun., J85.","DOI":"10.1128\/IAI.00177-17"},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.imlet.2016.02.009","article-title":"A peptide immunization approach to counteract a Staphylococcus aureus protease defense against host immunity","volume":"172","author":"Jordan","year":"2016","journal-title":"Immunol. Lett."},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1159\/000351458","article-title":"Staphylococcal proteases aid in evasion of the human complement system","volume":"6","author":"Jusko","year":"2014","journal-title":"J. Innate Immun."},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1089\/dna.2024.0134","article-title":"Staphylococcus aureus proteases: Orchestrators of skin inflammation","volume":"43","author":"Kline","year":"2024","journal-title":"DNA Cell Biol."},{"key":"ref_177","doi-asserted-by":"crossref","unstructured":"Lehman, M.K., Nuxoll, A.S., Yamada, K.J., Kielian, T., Carson, S.D., and Fey, P.D. (2019). Protease-mediated growth of Staphylococcus aureus on host proteins Is opp3 dependent. mBio, 10.","DOI":"10.1128\/mBio.02553-18"},{"key":"ref_178","doi-asserted-by":"crossref","unstructured":"Pietrocola, G., Nobile, G., Rindi, S., and Speziale, P. (2017). Staphylococcus aureus manipulates innate immunity through own and host-expressed proteases. Front. Cell Infect. Microbiol., 7.","DOI":"10.3389\/fcimb.2017.00166"},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1007\/s00430-018-0573-y","article-title":"Interaction of host and Staphylococcus aureus protease-system regulates virulence and pathogenicity","volume":"208","author":"Singh","year":"2019","journal-title":"Med. Microbiol. Immunol."},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1007\/s10517-013-2051-2","article-title":"Effects of Staphylococcus aureus supernatants on human lymphocyte surface receptors","volume":"154","author":"Tyurin","year":"2013","journal-title":"Bull. Exp. Biol. Med."},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"2751","DOI":"10.1007\/s00203-020-01992-y","article-title":"Diclofenac mitigates virulence of multidrug-resistant Staphylococcus aureus","volume":"202","author":"Abbas","year":"2020","journal-title":"Arch. Microbiol."},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s42770-021-00655-4","article-title":"The promising anti-virulence activity of candesartan, domperidone, and miconazole on Staphylococcus aureus","volume":"53","author":"Gad","year":"2022","journal-title":"Braz. J. Microbiol."},{"key":"ref_183","doi-asserted-by":"crossref","unstructured":"Saleh, M.M., Yousef, N., Shafik, S.M., and Abbas, H.A. (2022). Attenuating the virulence of the resistant superbug Staphylococcus aureus bacteria isolated from neonatal sepsis by ascorbic acid, dexamethasone, and sodium bicarbonate. BMC Microbiol., 22.","DOI":"10.1186\/s12866-022-02684-x"},{"key":"ref_184","first-page":"e0314723","article-title":"Comparative evaluation of small molecules reported to be inhibitors of Staphylococcus aureus biofilm formation","volume":"2","author":"Campbell","year":"2023","journal-title":"mSpectrum"},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1007\/s11606-024-08674-1","article-title":"Identifying the best initial oral antibiotics for adults with community-acquired pneumonia: A network meta-analysis","volume":"39","author":"Kurotschka","year":"2024","journal-title":"J. Gen. Intern. Med."}],"container-title":["Microorganisms"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-2607\/13\/4\/852\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T17:12:57Z","timestamp":1760029977000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-2607\/13\/4\/852"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,9]]},"references-count":185,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2025,4]]}},"alternative-id":["microorganisms13040852"],"URL":"https:\/\/doi.org\/10.3390\/microorganisms13040852","relation":{},"ISSN":["2076-2607"],"issn-type":[{"value":"2076-2607","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,9]]}}}